Imagen de Portada

Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhi Wen, Shuai Shao, Yu Feng, Zheng Wang, Jianqiang Wu, Changxue Wu, Mingwu Tian
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cardiac Allograft Vasculopathy in Heart Transplantation From Circulatory Death Donors: A Systematic Review and Meta‐Analysis
por: Wasif Safdar, et al.
Publicado: (2026)

Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy
por: Rami Alharethi, et al.
Publicado: (2024)

Association Between Right Ventricular Dysfunction and Cardiac Allograft Vasculopathy in Pediatric Patients Following Heart Transplantation
por: Teruhiko Imamura
Publicado: (2026)

Right Ventricular Dysfunction by Echocardiography Is an Early Marker of Evolving Cardiac Allograft Vasculopathy in Children After Heart Transplantation
por: Judith Namuyonga, et al.
Publicado: (2025)

Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes
por: Masaki Tsuji, et al.
Publicado: (2025)

Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?
por: Jacqueline I. Kim, et al.
Publicado: (2026)

Risk Index Predicts Pediatric Heart Allograft Non‐Utilization
por: Jake Lynn, et al.
Publicado: (2024)

Association of Donor Vascular Endothelial Growth Factor Gene Polymorphism With Acute Renal Allograft Rejection
por: Narayan Prasad, et al.
Publicado: (2024)

Long‐Term Chronic Lung Allograft Dysfunction‐Free Survival Following Lung Transplant in the Presence of Donor‐Specific Antibodies
por: Benjamin Grobman, et al.
Publicado: (2025)

Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
por: Ana Khazan, et al.
Publicado: (2026)

Evolving Long‐Term Outcomes of Heart Transplantation Using COVID‐19 Positive Donors
por: Ye In Christopher Kwon, et al.
Publicado: (2026)

Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
por: Eishan Ashwat, et al.
Publicado: (2025)

Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)

Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience
por: Gal Rubinstein, et al.
Publicado: (2025)

Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
por: Armaan F. Akbar, et al.
Publicado: (2024)

Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
por: Meagan O. Rogers, et al.
Publicado: (2024)

Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction
por: Johanna P. van Gemert, et al.
Publicado: (2025)

Associated Clinical and Laboratory Markers of Donor on Allograft Function After Heart Transplant
por: Renato Braulio
Publicado: (2016)

Intraoperative Hemodynamic Monitoring and Prediction of Early Allograft Dysfunction Following Living Donor Liver Transplantation: A Systematic Review
por: Audrey E. Brown, et al.
Publicado: (2025)

Donor Characteristics and Outcomes of Pediatric Heart Transplantation in South Korea
por: Susan Taejung Kim, et al.
Publicado: (2024)

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
por: Vaisak O. Nair, et al.
Publicado: (2025)

Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
por: Ye In Christopher Kwon, et al.
Publicado: (2026)

Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
por: Ananya Gorrai, et al.
Publicado: (2026)

Project Donor: A National Intervention to Improve the Health of Potential Living Donors
por: Ali B. Abbasi, et al.
Publicado: (2025)

Reduced Surgical Complications After Deceased‐Donor Kidney Transplantation Using Inverted Allograft and Ultrashort Ureteroureterostomy: A Single‐Center Experience
por: Rafael Azevedo Foinquinos, et al.
Publicado: (2025)

Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation
por: Javier M. Zamora‐Olaya, et al.
Publicado: (2024)

Potential Role of SGLT‐2 Inhibitors in Improving Allograft Function and Reducing Rejection in Kidney Transplantation
por: Mehmet Emin Demir, et al.
Publicado: (2025)

Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes
por: Ahad Firoz, et al.
Publicado: (2024)

Organ Donor Potential After Extracorporeal Cardiopulmonary Resuscitation for Out‐of‐Hospital Cardiac Arrest: A Post‐Hoc Analysis of a Randomized Controlled Trial
por: Hanne C. R. Verberght, et al.
Publicado: (2025)

Diagnostic and Prognostic Value of Myocardial Extracellular Volume Fraction Assessed Using Cardiovascular Magnetic Resonance in Patients With Restrictive Cardiac Allograft Physiology
por: Masaki Tsuji, et al.
Publicado: (2025)

Delayed‐Onset Renal Allograft Compartment Syndrome in a Pediatric Kidney Transplant Recipient: The Role of Surgical Re‐Evaluation
por: Buğra Otludil, et al.
Publicado: (2025)

Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors
por: Christine E. Koval, et al.
Publicado: (2026)

Possible Donor‐Derived Tuberculosis in an Orthotopic Heart Transplant Recipient
por: Phani V. Akella, et al.
Publicado: (2026)

Skin Elasticity: A Potential Surrogate Marker for Facial Allograft Skin Fibrosis—A Case Series
por: Viola A. Stögner, et al.
Publicado: (2025)

Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
por: Iris Feng, et al.
Publicado: (2025)

Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era
por: Lana Hasan, et al.
Publicado: (2025)

Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States
por: Shivank Madan, et al.
Publicado: (2024)

Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
por: Majd Alsoubani, et al.
Publicado: (2025)

Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
por: Cathrine M. Moeller, et al.
Publicado: (2024)

Significant Long‐Term Prevention of High Sensitization After Kidney Allograft Failure by Maintaining Calcineurin Inhibitor‐Based Immunosuppression
por: Anna Allesina, et al.
Publicado: (2024)